TECREGEN

Pharmaceutical products, medical and veterinary preparations; hygiene preparations for medical use; pharmaceutical substances and preparations, in particular nanobodies; therapeutic antibody fragments for the treatment of autoimmune diseases; nanobodies used as medicinal preparations for the treatment of autoimmune and cancerous diseases; chemical and biochemical preparations for medical use; nanobodies used as chemical preparations for medical use; biotechnological preparations for medical use; diagnostic preparations for medical use; nanobodies used as diagnostic preparations for medical use; medicines; medicines containing nanobodies.

Surgical, medical, dental and veterinary apparatus and instruments; medical instruments for administering nanobody-based agents.

Scientific and technological services as well as research and design services relating thereto; industrial analysis, industrial research and industrial design services; design, development and programming of software; scientific and medical research and development; research and development in the field of nanobody technology; consultancy in the field of nanobody technology and biotechnological research; development and maintenance of genetic banks of antibody fragments; database design and development; Software as a Service (SaaS); computer Platform as a Service (PaaS); hosting of computer databases.

Medical services; personalized medical diagnostic services based on nanobody technology; medical testing for the diagnosis and treatment of persons.